Latest Stock Market News

Over the past four months, nearly two-thirds of recent IPOs have maintained their value, despite a general market decline. Strong investor interest and confidence in the future potential of newly listed companies have helped them weather the downturn better than established stocks.

The Indian rupee slightly appreciated on Monday, primarily aided by the strength of other regional currencies, although its rise was curbed by importers dollar demands and potential equity outflows. The rupee s 1-month implied volatility decreased, while Asian currencies benefited from a weaker dollar due to falling US retail sales and delayed trade tariffs.

JM Financial recommends buying Yatra Online shares with a revised target price of Rs 140 within a year. Yatra Online saw significant growth in total income from last year. Adjustments due to Globe Travels consolidation have influenced revenue and EBITDA forecasts. Promoters hold 64.46% stake, while FIIs and DIIs own smaller percentages.

Maxvolt Energy Industries will finalize its IPO share allotment process on Monday. Investors can check the allotment status on the NSE website or through Bigshare Services. The company s IPO experienced a subscription of 3 times, indicating a significant interest from investors.

Chandan Healthcare is set to debut on the NSE SME platform with shares offered at Rs 159 apiece. The company, operating a diagnostic network across Northern India, received a 7x subscription for its IPO. The company derives a significant portion of its revenue from pathology and radiology services.

Bharat Heavy Electricals Ltd (BHEL) secured a Rs 6,700 crore order from Singareni Collieries Company to establish an 800 MW thermal power unit in Telangana. BHEL will handle the design, engineering, manufacturing, supply, and more for the project, which underscores its role in India s energy security.

Shibani Sircar Kurian of Kotak Mahindra Asset Management highlights that large private and select public sector banks, the healthcare sector, technology sector, and discretionary consumption brands focused on rural and middle-class segments show promising growth. Financial stability, earnings growth in healthcare, and technology advancements are key positive indicators amidst market volatility favoring large-cap investments.

Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss in the previous year. Revenue increased by 35% YoY to Rs 3,388 crore. Strong performance in the India and Europe markets contributed to the growth.

Anand Tandon notes smaller companies often struggle during downturns with poor performance and high market valuations. He emphasizes the potential in larger firms like Bharti due to their stable free cash flows and pricing power. Market conditions remain uncertain, making it risky to invest in lesser-known firms. The Indian economic growth remains primarily driven by internal factors.

ABFRL share price: Revenue from operations increased by 3.3% year-on-year, reaching Rs 4,304.7 crore, up from Rs 4,166.7 crore in Q3 FY23, driven by consistent demand across its portfolio.